Genflow Biosciences Plc (GB:GENF) has released an update.
Genflow Biosciences Plc, a biotech firm specializing in longevity research, has announced the temporary suspension of its shares on the London Stock Exchange due to a delay in publishing its Annual Financial Report. The company assures that this delay, caused by a longer-than-expected audit process, does not reflect any issues with its economic position or cash flow. The suspension will allow Genflow additional time to finalize and disclose the report.
For further insights into GB:GENF stock, check out TipRanks’ Stock Analysis page.
